N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification

This publication has 31 references indexed in Scilit:

• Synergistic efficacy of a novel combination therapy controls growth of Bcl-x_Lbountiful neuroblastoma cells by increasing differentiation and apoptosis
  Cancer Biology & Therapy, 2011
• Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells
  Neuroscience Letters, 2011
• Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
  BMC Developmental Biology, 2011
• N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53
  Biochemical Pharmacology, 2009
• High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
  Proceedings of the National Academy of Sciences, 2008
• Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
  Cancer Research, 2007
• Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells
  Neuroscience Letters, 2006
• MYCN amplification remains prognostically strong 20 years after its “clinical debut”
  European Journal of Cancer, 2004
• MYCN in neuronal tumours
  Cancer Letters, 2004
• NF-κB in cancer: from innocent bystander to major culprit
  Nature Reviews Cancer, 2002